NCT06690723View on ClinicalTrials.gov

Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Dapagliflozin (Forxiga)

Dapagliflozin plus lifestyle modification

DRUG

Vitamin D3 ( Colecalciferol)

Vitamin D3 plus lifestyle modification

DRUG

Vitamin D3 plus Dapagliflozin

Vitamin D3 plus Dapagliflozin plus lifestyle modification

BEHAVIORAL

Lifestyle modification

Lifestyle modification alone

Trial Locations (1)

94300

University Malaysia Sarawak, Sarawak

All Listed Sponsors
lead

University Malaysia Sarawak

OTHER